The Mesothelioma Guide Blog

One of the diagnostic challenges for mesothelioma is distinguishing between a malignant disease and a benign one. A protein called c-MET is another biomarker to help tell the...

Update: This podcast was recorded in September, one month before the FDA approved nivolumab and ipilimumab for pleural mesothelioma. This news altered the plans for a lot of...

Sarcomatoid mesothelioma is the rarest of the three cell types of mesothelioma. Its uncommon nature is one reason why it’s challenging to identify and diagnose. A new biomarker...

The highly regarded Brigham and Women’s Hospital is hosting a monthly online mesothelioma support group titled “Living With Mesothelioma.” The next meeting is this Sunday,...

There’s an ongoing discussion about which surgery is best for pleural mesothelioma. Is it better to remove a lung with extrapleural pneumonectomy (EPP)? Or is the less-invasive...

The Science Advisory Committee on Chemicals (SACC) issued a scathing report about the United States Environmental Protection Agency’s attitude regarding asbestos. It’s far...

Note: This blog was originally published on September 3, 2020 and was updated on January 23, 2023 with more information regarding mesothelioma quality of life.  Mesothelioma is...

Exposure to asbestos has no limitations. It can happen nearly anywhere, mostly due to asbestos being used everywhere for decades. Even your home — yes, your home — may be...

Dr. Lara Traeger remembers the exact circumstances of what led to her research. An early-stage lung cancer patient undergoing treatment expressed anxiety and stress regarding the...

When a clinical trial begins, the researchers in charge will pick specific criteria for their study. These rules may exclude a segment of people, for any number of reasons. A...